Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
GDUFA IV: Sponsors May See ANDA Prioritization If Some Production Aspects Onshored
Mar 09 2026
•
By
Derrick Gingery
Domestic manufacturing could be added to the FDA ANDA prioritization MaPP.
(Shutterstock)
More from Generics
More from Products